NetworkNewsBreaks – Hoth Therapeutics Inc. (NASDAQ: HOTH) Shares Pricing of $7M Public Offering
Hoth Therapeutics (NASDAQ: HOTH), a patient-focused biopharmaceutical company, has announced the pricing of its underwritten public offering. The offering, consisting of 8,235,294 shares of common stock and priced at the market under Nasdaq requirements, is available at a public offering price of $0.85 per share. Based on that information, the offering should result in approximately $7 million gross proceeds for the company, before standard deductions. Hoth plans on using the proceeds from the offering for working capital and general corporate purposes. The announcement also noted that Hoth granted the underwriters a 45-day option to purchase additional shares. According to the announcement, the…